Idexx Laboratories
(IDXX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 1,485,807 | 1,377,058 | 1,293,338 | 1,218,689 | 1,103,392 |
| Cost of Goods | 669,691 | 620,940 | 594,190 | 572,183 | 524,769 |
| Gross Profit | 816,116 | 756,118 | 699,148 | 646,506 | 578,623 |
| Operating Expenses | 556,552 | 490,296 | 436,775 | 410,464 | 375,511 |
| Operating Income | 260,255 | 266,762 | 262,563 | 236,225 | 203,881 |
| Interest Expense | 15,429 | 5,386 | 3,848 | 3,547 | 2,415 |
| Other Income | 1,729 | 1,885 | 1,902 | 1,744 | 663 |
| Pre-tax Income | 246,555 | 263,261 | 260,617 | 234,422 | 202,129 |
| Income Tax | 64,604 | 75,467 | 82,330 | 72,668 | 60,809 |
| Net Income Continuous | 181,951 | 187,794 | 178,287 | 161,754 | 141,320 |
| Minority Interests | 45 | -6 | 20 | -32 | 36 |
| Net Income | $181,906 | $187,800 | $178,267 | $161,786 | $141,284 |
| EPS Basic Total Ops | 1.82 | 1.77 | 1.62 | 1.43 | 1.23 |
| EPS Basic Continuous Ops | 1.82 | 1.77 | 1.62 | 1.42 | 1.22 |
| EPS Diluted Total Ops | 1.79 | 1.74 | 1.59 | 1.39 | 1.19 |
| EPS Diluted Continuous Ops | 1.79 | 1.74 | 1.59 | 1.39 | 1.19 |
| EBITDA(a) | $319,143 | $321,358 | $314,971 | $284,427 | $249,837 |